In This Section

A Comprehensive Cancer Center Designated by the National Cancer Institute

The UChicago Advantage

Despite years of intense effort, researchers are still fighting a long battle against cancer. Enhanced screening and targeted therapies have improved the outlook for many cancer patients, but for others with malignancies, such as lung cancer or pancreatic cancer, overall survival rates have not improved significantly in the past few decades.

At the UCCCC, we are advancing innovative ideas in a setting that connects the laboratory, clinic, and community. Discoveries forged in this integrated environment have a more immediate and broader impact. Furthermore, a major investment in systems-level biology provides a sophisticated approach that holds great potential to unravel the complexities of cancer.

The UCCCC has an unwavering focus on cancer research and treatment. Our programs emphasize translational and interdisciplinary research through collaborations among a diverse and dedicated team of outstanding basic, translational, clinical and population researchers, caregivers, and trainees.

At the UCCCC, we have long been recognized for our strength in basic and clinical research, particularly for our major contributions to early phase clinical trials and drug development. We bring together more than 210 UChicago laboratory and clinical scientists who are focusing their efforts on four broad fronts:

  • Intensive prevention programs for individuals at high risk;
  • Ground-breaking technologies for early detection;
  • Development of novel therapies; and
  • Survivorship.

Events